Trademark Overview
On Wednesday, November 5, 2025, a trademark application was filed for P2RISM with the United States Patent and Trademark Office. The USPTO has given the P2RISM trademark a serial number of 99480778. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, July 9, 2026. This trademark is owned by GrayMatters Health Ltd.. The P2RISM trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Downloadable computer software for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; downloadable interactive audio-visual software based on machine learning for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; downloadable software applications for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; downloadable interactive audio-visual software applications based on machine learning for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders
Providing non-downloadable online software for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; Software as a Service (SaaS) services featuring software for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; Platform as a Service (PaaS) services featuring software platforms for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; providing non-downloadable online software, namely, interactive audio-visual software based on machine learning for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; Software as a Service (SaaS) services featuring interactive audio visual software based on machine learning for creating computer simulations for use in the treatment of mental, neurologic and immune related disorders; Platform as a Service (PaaS) services featuring interactiv...
